PAREXEL INTERNATIONAL TO PARTICIPATE IN LAZARD CAPITAL MEDICAL TECHNOLOGY / LIFE SCIENCE TOOLS DAY AND DEUTSCHE BANK MEDTOOLS INVESTOR SUMMIT
Boston, MA, November 29, 2010 – PAREXEL International Corporation (NASDAQ: PRXL) announced today it will be participating in the Lazard Capital Medical Technology / Life Science Tools Day in Denver, CO on Thursday, December 2, 2010.
PAREXEL will also be participating in the Deutsche Bank MedTools Investor Summit in Boston, MA on Tuesday, December 7, 2010.
About PAREXEL International
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 54 countries around the world, and has approximately 10,170 employees. For more information about PAREXEL International visit www.PAREXEL.com.
PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.